pathway,nums,percent,pvalue
Adherens junction,93,0.7204301075268817,0.0
Adrenergic signaling in cardiomyocytes,156,0.6987179487179487,0.0
Alzheimer's disease,175,0.68,0.0
AMPK signaling pathway,128,0.609375,0.0
Antigen processing and presentation,97,0.5051546391752577,0.0
Axon guidance,183,0.4207650273224044,0.0
B cell receptor signaling pathway,85,0.7294117647058823,0.0
Carbon metabolism,126,0.7222222222222222,0.0
Cardiac muscle contraction,87,0.45977011494252873,0.0
Cell adhesion molecules (CAMs),169,0.31952662721893493,0.0
Chagas disease (American trypanosomiasis),101,0.8613861386138614,0.0
Chemokine signaling pathway,204,0.5735294117647058,0.0
Complement and coagulation cascades,94,0.26595744680851063,0.0
Cytokine-cytokine receptor interaction,326,0.4049079754601227,0.0
Cytosolic DNA-sensing pathway,80,0.75,0.0
Dopaminergic synapse,138,0.4492753623188406,0.0
ECM-receptor interaction,89,0.4044943820224719,0.0
Fc epsilon RI signaling pathway,68,0.7058823529411765,0.0
Fc gamma R-mediated phagocytosis,97,0.9484536082474226,0.0
Focal adhesion,204,0.7549019607843137,0.0
Glucagon signaling pathway,108,0.39814814814814814,0.0
Hematopoietic cell lineage,98,0.45918367346938777,0.0
HTLV-I infection,283,0.6678445229681979,0.0
Huntington's disease,194,0.6443298969072165,0.0
IL-17 signaling pathway,93,0.4946236559139785,0.0
Inflammatory bowel disease (IBD),59,0.7966101694915254,0.0
Inositol phosphate metabolism,73,0.3561643835616438,0.0
JAK-STAT signaling,19,0.7894736842105263,0.0
Jak-STAT signaling pathway,159,0.4716981132075472,0.0
Leukocyte transendothelial migration,121,0.71900826446281,0.0
Lysine degradation,67,0.4925373134328358,0.0
MAPK signaling pathway,252,0.6388888888888888,0.0
Metabolic pathways,1315,0.39923954372623577,0.0
Natural killer cell mediated cytotoxicity,123,0.4959349593495935,0.0
NF-kappa B signaling pathway,114,0.7807017543859649,0.0
NOD-like receptor signaling pathway,220,0.6363636363636364,0.0
Nucleotide excision repair,58,0.8103448275862069,0.0
Osteoclast differentiation,140,0.7928571428571428,0.0
Oxidative phosphorylation,151,0.5960264900662252,0.0
Parkinson's disease,144,0.6875,0.0
Peroxisome,87,0.5977011494252874,0.0
PI3K-Akt signaling pathway,373,0.5603217158176944,0.0
Platelet activation,126,0.6904761904761905,0.0
PPAR signaling pathway,90,0.3,0.0
Protein digestion and absorption,110,0.35454545454545455,0.0
Rap1 signaling pathway,218,0.6330275229357798,0.0
Regulation of actin cytoskeleton,239,0.7322175732217573,0.0
Retrograde endocannabinoid signaling,150,0.41333333333333333,0.0
Ribosome,187,0.5882352941176471,0.0
Ribosome biogenesis in eukaryotes,125,0.44,0.0
"Ribosome, eukaryotes",98,0.7142857142857143,0.0
RIG-I-like receptor signaling pathway,73,0.684931506849315,0.0
RNA transport,167,0.7664670658682635,0.0
T cell receptor signaling pathway,125,0.632,0.0
Th1 and Th2 cell differentiation,89,0.6404494382022472,0.0
Th17 cell differentiation,107,0.7102803738317757,0.0
TNF signaling pathway,115,0.8608695652173913,0.0
Toll-like receptor signaling pathway,104,0.7596153846153846,0.0
Nucleocytoplasmic transport,117,0.7777777777777778,0.0
ATP-dependent chromatin remodeling,136,0.45588235294117646,0.0
Polycomb repressive complex,84,0.6666666666666666,0.0
JAK-STAT signaling pathway,171,0.4619883040935672,0.0
Viral protein interaction with cytokine and cytokine receptor,95,0.47368421052631576,0.0
Cell adhesion molecules,182,0.29120879120879123,0.0
Neutrophil extracellular trap formation,208,0.4423076923076923,0.0
C-type lectin receptor signaling pathway,112,0.7142857142857143,0.0
Thermogenesis,231,0.6320346320346321,0.0
Pathways in cancer,543,0.56353591160221,0.0
MicroRNAs in cancer,303,0.33663366336633666,0.0
Human immunodeficiency virus 1 infection,239,0.6401673640167364,0.0
Hepatitis B,163,0.8773006134969326,0.0
Influenza A,173,0.7225433526011561,0.0
Measles,145,0.8068965517241379,0.0
Herpes simplex virus 1 infection,458,0.34279475982532753,0.0
Human cytomegalovirus infection,255,0.6980392156862745,0.0
Kaposi sarcoma-associated herpesvirus infection,223,0.6367713004484304,0.0
Epstein-Barr virus infection,230,0.6782608695652174,0.0
Human papillomavirus infection,361,0.5373961218836565,0.0
Yersinia infection,135,0.8814814814814815,0.0
Tuberculosis,180,0.7,0.0
Bacterial invasion of epithelial cells,76,0.8026315789473685,0.0
Amoebiasis,107,0.6915887850467289,0.0
Malaria,57,0.5789473684210527,0.0
Toxoplasmosis,109,0.926605504587156,0.0
Leishmaniasis,70,0.9285714285714286,0.0
Rheumatoid arthritis,87,0.6091954022988506,0.0
Autoimmune thyroid disease,78,0.24358974358974358,0.0
Inflammatory bowel disease,62,0.7258064516129032,0.0
Allograft rejection,62,0.3225806451612903,0.0
Graft-versus-host disease,62,0.3064516129032258,0.0
Primary immunodeficiency,36,0.16666666666666666,0.0
Parkinson disease,264,0.5909090909090909,0.0
Amyotrophic lateral sclerosis,369,0.5799457994579946,0.0
Huntington disease,302,0.5529801324503312,0.0
Lipid and atherosclerosis,216,0.6574074074074074,0.0
Viral myocarditis,87,0.5747126436781609,0.0
Type II diabetes mellitus,48,0.4375,0.0
Type I diabetes mellitus,69,0.34782608695652173,0.0
AGE-RAGE signaling pathway in diabetic complications,101,0.9405940594059405,0.0
Autophagy - animal,167,0.5988023952095808,0.001
Fatty acid degradation,53,0.33962264150943394,0.001
Intestinal immune network for IgA production,45,0.6222222222222222,0.001
mRNA surveillance pathway,105,0.5333333333333333,0.001
NADH dehydrogenase (ubiquinone) 1 beta subcomplex,14,0.21428571428571427,0.001
Neuroactive ligand-receptor interaction,393,0.061068702290076333,0.001
Phagosome,192,0.5208333333333334,0.001
Protein processing in endoplasmic reticulum,183,0.5355191256830601,0.001
Ras signaling pathway,242,0.5165289256198347,0.001
"Valine, leucine and isoleucine degradation",57,0.45614035087719296,0.001
Motor proteins,196,0.5867346938775511,0.001
Chronic myeloid leukemia,76,0.9605263157894737,0.001
Pertussis,77,0.7012987012987013,0.001
Pathways of neurodegeneration - multiple diseases,471,0.505307855626327,0.001
Non-alcoholic fatty liver disease,156,0.8461538461538461,0.001
Basal transcription factors,45,0.8,0.002
Citrate cycle (TCA cycle),32,0.71875,0.002
Fatty acid metabolism,64,0.234375,0.002
Glycerophospholipid metabolism,99,0.30303030303030304,0.002
Mitophagy - animal,68,0.4852941176470588,0.002
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex,16,0.5,0.002
Neurotrophin signaling pathway,121,0.6776859504132231,0.002
Non-alcoholic fatty liver disease (NAFLD),151,0.8344370860927153,0.002
Pentose and glucuronate interconversions,37,0.08108108108108109,0.002
mmuK signaling pathway,301,0.6445182724252492,0.002
Proteoglycans in cancer,205,0.7560975609756098,0.002
beta-Alanine metabolism,37,0.35135135135135137,0.003
Inflammatory mediator regulation of TRP channels,127,0.30708661417322836,0.003
Propanoate metabolism,34,0.6764705882352942,0.003
Protein export,31,0.3548387096774194,0.003
Gastric cancer,150,0.4666666666666667,0.003
Small cell lung cancer,93,0.8817204301075269,0.003
Human T-cell leukemia virus 1 infection,249,0.7389558232931727,0.003
Platinum drug resistance,80,0.75,0.003
Aldosterone-regulated sodium reabsorption,39,0.4358974358974359,0.004
Immunoproteasome,18,0.7777777777777778,0.004
Alzheimer disease,383,0.5274151436031331,0.004
BMP signaling,20,0.2,0.005
Herpes simplex infection,215,0.6558139534883721,0.006
Prolactin signaling pathway,74,0.4594594594594595,0.006
Tryptophan metabolism,54,0.3148148148148148,0.006
Cellular senescence,183,0.6830601092896175,0.006
Renal cell carcinoma,68,0.75,0.006
Cell cycle,157,0.7834394904458599,0.007
Glycolysis / Gluconeogenesis,70,0.3142857142857143,0.007
Pancreatic cancer,76,0.8947368421052632,0.007
RNA degradation,90,0.4111111111111111,0.008
"Growth hormone synthesis, secretion and action",117,0.5811965811965812,0.009
Asthma,25,0.36,0.011
2-Oxocarboxylic acid metabolism,34,0.5588235294117647,0.012
FoxO signaling pathway,133,0.5263157894736842,0.012
Galactose metabolism,34,0.20588235294117646,0.012
Relaxin signaling pathway,129,0.689922480620155,0.012
"Spliceosome, U4/U6.U5 tri-snRNP",32,0.53125,0.013
Viral carcinogenesis,228,0.6885964912280702,0.014
Fluid shear stress and atherosclerosis,147,0.7142857142857143,0.014
Alcoholic liver disease,141,0.7163120567375887,0.014
Spliceosome,186,0.5645161290322581,0.015
Necroptosis,175,0.5714285714285714,0.016
TGF-beta signaling,8,1.0,0.017
Systemic lupus erythematosus,149,0.20134228187919462,0.017
Biosynthesis of amino acids,84,0.39285714285714285,0.018
Biosynthesis of cofactors,152,0.3092105263157895,0.018
Long-term depression,61,0.3442622950819672,0.019
"Spliceosome, 35S U5-snRNP",36,0.3888888888888889,0.02
Hippo signaling pathway - multiple species,27,0.3333333333333333,0.02
Lipoic acid metabolism,19,0.42105263157894735,0.021
Glioma,74,0.7027027027027027,0.021
Cholinergic synapse,114,0.5526315789473685,0.022
Toll-like receptor signaling,15,0.8666666666666667,0.023
Vasopressin-regulated water reabsorption,44,0.6818181818181818,0.023
Prion disease,267,0.6666666666666666,0.023
Arginine biosynthesis,20,0.2,0.024
Exon junction complex (EJC),22,0.5,0.024
Chagas disease,103,0.7961165048543689,0.024
Cocaine addiction,48,0.25,0.024
Colorectal cancer,88,0.6931818181818182,0.026
Endocrine and other factor-regulated calcium reabsorption,61,0.08196721311475409,0.027
Hippo signaling pathway -multiple species,26,0.34615384615384615,0.027
cAMP signaling pathway,224,0.48660714285714285,0.028
Longevity regulating pathway - multiple species,62,0.7580645161290323,0.028
PD-L1 expression and PD-1 checkpoint pathway in cancer,88,0.8068181818181818,0.028
beta-Oxidation,13,0.7692307692307693,0.029
APC/C complex,14,0.21428571428571427,0.031
Endometrial cancer,58,0.3793103448275862,0.031
Fatty acid elongation,29,0.2413793103448276,0.032
Starch and sucrose metabolism,36,0.16666666666666666,0.032
Wnt signaling pathway,180,0.3388888888888889,0.033
Phosphatidylinositol signaling system,99,0.31313131313131315,0.034
Nucleotide metabolism,84,0.47619047619047616,0.034
Staphylococcus aureus infection,128,0.1875,0.034
Amphetamine addiction,69,0.34782608695652173,0.035
"Aminoacyl-tRNA biosynthesis, eukaryotes",38,0.42105263157894735,0.039
"Lysine degradation, lysine => saccharopine => acetoacetyl-CoA",11,1.0,0.039
Oocyte meiosis,123,0.5609756097560976,0.039
VEGF signaling pathway,58,0.7068965517241379,0.039
Endocytosis,297,0.5117845117845118,0.043
Ovarian steroidogenesis,65,0.13846153846153847,0.044
Cul4-DDB1-DDB2 complex,6,0.5,0.046
Proteasome,47,0.7021276595744681,0.046
Hedgehog signaling pathway,58,0.46551724137931033,0.048
Hepatitis C,166,0.7831325301204819,0.049
Collecting duct acid secretion,27,0.1111111111111111,0.051
Cul3-SPOP complex,5,0.6,0.053
Oxytocin signaling pathway,154,0.4155844155844156,0.053
Non-small cell lung cancer,72,0.6527777777777778,0.053
Insulin resistance,110,0.7636363636363637,0.054
Apoptosis,137,0.8613138686131386,0.055
"Propanoyl-CoA metabolism, propanoyl-CoA => succinyl-CoA",4,0.75,0.058
"F-type ATPase, eukaryotes",17,0.4117647058823529,0.06
Drug metabolism - cytochrome P450,72,0.20833333333333334,0.062
Melanoma,72,0.5555555555555556,0.066
Longevity regulating pathway,90,0.7111111111111111,0.068
Pyrimidine metabolism,107,0.4672897196261682,0.069
Breast cancer,147,0.42857142857142855,0.077
"Adenine ribonucleotide biosynthesis, IMP => ADP,ATP",20,0.25,0.078
"N-glycan biosynthesis, complex type",16,0.3125,0.084
Cul4-DDB1-CSA complex,6,0.6666666666666666,0.085
Estrogen signaling pathway,134,0.4701492537313433,0.086
Hippo signaling pathway,158,0.5759493670886076,0.089
Prostate cancer,99,0.5858585858585859,0.091
Signaling pathways regulating pluripotency of stem cells,141,0.41843971631205673,0.099
Pentose phosphate pathway,34,0.14705882352941177,0.102
Melanogenesis,100,0.26,0.109
Alcoholism,205,0.28292682926829266,0.109
One carbon pool by folate,19,0.2631578947368421,0.115
Aminoacyl-tRNA biosynthesis,84,0.15476190476190477,0.118
"C1-unit interconversion, eukaryotes",6,0.5,0.118
Hepatocellular carcinoma,174,0.6149425287356322,0.119
Legionellosis,60,0.7666666666666667,0.119
"Malonate semialdehyde pathway, propanoyl-CoA => acetyl-CoA",6,0.5,0.124
African trypanosomiasis,39,0.20512820512820512,0.125
ErbB signaling pathway,86,0.5116279069767442,0.127
"Guanine ribonucleotide biosynthesis IMP => GDP,GTP",12,0.25,0.129
Coronavirus disease - COVID-19,249,0.7108433734939759,0.129
Central carbon metabolism in cancer,69,0.5072463768115942,0.133
Nuclear pore complex,41,0.6585365853658537,0.137
Pyruvate metabolism,44,0.75,0.138
Insulin signaling pathway,143,0.6083916083916084,0.14
Thiamine metabolism,15,0.2,0.147
Fructose and mannose metabolism,38,0.21052631578947367,0.151
Arrhythmogenic right ventricular cardiomyopathy,77,0.4155844155844156,0.151
Circadian rhythm,37,0.16216216216216217,0.153
Hypertrophic cardiomyopathy (HCM),84,0.5714285714285714,0.162
Thyroid cancer,37,0.35135135135135137,0.168
Glyoxylate and dicarboxylate metabolism,32,0.375,0.17
Base excision repair,49,0.3877551020408163,0.171
Basal cell carcinoma,63,0.047619047619047616,0.178
"Citrate cycle (TCA cycle, Krebs cycle)",24,0.5,0.185
Dorso-ventral axis formation,26,0.6153846153846154,0.185
Tight junction,179,0.659217877094972,0.193
EGFR tyrosine kinase inhibitor resistance,79,0.569620253164557,0.196
Cytochrome c oxidase,25,0.16,0.198
Holo-TFIIH complex,10,0.7,0.2
Sphingolipid signaling pathway,127,0.7559055118110236,0.2
p53 signaling pathway,74,0.6891891891891891,0.228
COPII complex,11,0.5454545454545454,0.233
Biosynthesis of unsaturated fatty acids,36,0.08333333333333333,0.238
eIF4F complex,8,0.375,0.245
Arrhythmogenic right ventricular cardiomyopathy (ARVC),72,0.4722222222222222,0.249
Olfactory transduction,2230,0.0013452914798206279,0.249
Porphyrin and chlorophyll metabolism,41,0.07317073170731707,0.254
Dilated cardiomyopathy,94,0.5531914893617021,0.254
Gap junction,86,0.47674418604651164,0.256
Glutathione metabolism,74,0.36486486486486486,0.257
Fat digestion and absorption,43,0.06976744186046512,0.26
Porphyrin metabolism,43,0.06976744186046512,0.272
GABAergic synapse,91,0.2087912087912088,0.274
ABC transporters,52,0.25,0.281
Acute myeloid leukemia,70,0.7142857142857143,0.284
Arachidonic acid metabolism,95,0.09473684210526316,0.288
Ubiquitin mediated proteolysis,151,0.6357615894039735,0.303
Carbohydrate digestion and absorption,49,0.3877551020408163,0.306
"Leucine degradation, leucine => acetoacetate + acetyl-CoA",13,0.23076923076923078,0.311
MAPK (JNK) signaling,21,0.14285714285714285,0.313
Survival motor neuron (SMN) complex,9,0.4444444444444444,0.314
Mineral absorption,56,0.05357142857142857,0.316
Phosphonate and phosphinate metabolism,6,0.5,0.316
"Glycine, serine and threonine metabolism",40,0.225,0.32
"Spliceosome, U2-snRNP",21,0.47619047619047616,0.322
Drug metabolism - other enzymes,92,0.32608695652173914,0.332
Tyrosine metabolism,41,0.12195121951219512,0.333
Spinocerebellar ataxia,141,0.5035460992907801,0.333
Hypertrophic cardiomyopathy,91,0.5604395604395604,0.334
Phospholipase D signaling pathway,150,0.72,0.34
Metabolism of xenobiotics by cytochrome P450,75,0.22666666666666666,0.357
Endocrine resistance,93,0.6666666666666666,0.36
"Fatty acid biosynthesis, elongation, mitochondria",6,0.5,0.363
Thyroid hormone signaling pathway,120,0.725,0.376
Butanoate metabolism,28,0.4642857142857143,0.378
GnRH secretion,63,0.3968253968253968,0.395
"RNA polymerase III, eukaryotes",18,0.2222222222222222,0.398
Renin-angiotensin system,37,0.08108108108108109,0.428
Apelin signaling pathway,145,0.6068965517241379,0.433
Arginine and proline metabolism,57,0.19298245614035087,0.436
Methionine degradation,11,0.2727272727272727,0.439
Chemical carcinogenesis - DNA adducts,84,0.2619047619047619,0.443
"Phosphatidylcholine (PC) biosynthesis, choline => PC",6,0.5,0.444
Autophagy - other,32,0.09375,0.451
Nicotinate and nicotinamide metabolism,45,0.06666666666666667,0.451
Glutamatergic synapse,116,0.20689655172413793,0.455
Transcriptional misregulation in cancer,224,0.48214285714285715,0.458
Progesterone-mediated oocyte maturation,92,0.6630434782608695,0.461
HIF-1 signaling pathway,120,0.7833333333333333,0.465
Adipocytokine signaling pathway,73,0.5342465753424658,0.478
SNARE interactions in vesicular transport,33,0.5757575757575758,0.487
Viral life cycle - HIV-1,61,0.7540983606557377,0.49
Vascular smooth muscle contraction,145,0.4482758620689655,0.502
Long-term potentiation,67,0.23880597014925373,0.503
Purine metabolism,185,0.4594594594594595,0.513
Diabetic cardiomyopathy,211,0.7772511848341233,0.515
N-Glycan biosynthesis,53,0.32075471698113206,0.522
Glycerolipid metabolism,64,0.15625,0.524
Bladder cancer,41,0.5121951219512195,0.525
RF-C complex,5,0.6,0.532
Sphingolipid metabolism,57,0.19298245614035087,0.535
Amyotrophic lateral sclerosis (ALS),52,0.5384615384615384,0.542
Homologous recombination,42,0.16666666666666666,0.555
Aldosterone synthesis and secretion,105,0.37142857142857144,0.569
Notch signaling pathway,63,0.5238095238095238,0.577
Cholesterol metabolism,50,0.34,0.578
DNA replication,35,0.9714285714285714,0.602
"V-type ATPase, eukaryotes",24,0.3333333333333333,0.612
"Alanine, aspartate and glutamate metabolism",41,0.36585365853658536,0.613
Antifolate resistance,29,0.3448275862068966,0.613
MAPK (ERK1/2) signaling,8,0.375,0.616
Various types of N-glycan biosynthesis,43,0.37209302325581395,0.624
Cortisol synthesis and secretion,72,0.2777777777777778,0.645
GnRH signaling pathway,90,0.24444444444444444,0.662
Cushing syndrome,162,0.43209876543209874,0.677
Methionine salvage pathway,11,0.2727272727272727,0.691
Thyroid hormone synthesis,74,0.36486486486486486,0.713
Amino sugar and nucleotide sugar metabolism,52,0.23076923076923078,0.72
Choline metabolism in cancer,98,0.6020408163265306,0.721
Other types of O-glycan biosynthesis,43,0.13953488372093023,0.727
Sulfur metabolism,14,0.9285714285714286,0.749
cAMP signaling,15,0.4,0.751
Circadian entrainment,100,0.24,0.753
Chemical carcinogenesis - receptor activation,225,0.5555555555555556,0.757
Regulation of lipolysis in adipocytes,57,0.5087719298245614,0.77
BRCA1-associated genome surveillance complex (BASC),16,0.375,0.771
RPA complex,3,1.0,0.771
Chemical carcinogenesis - reactive oxygen species,223,0.6905829596412556,0.772
Hippo signaling,15,0.26666666666666666,0.783
Salmonella infection,253,0.7786561264822134,0.787
Prion diseases,34,0.5,0.794
MCM complex,6,0.5,0.796
Sm core complex,8,0.375,0.799
Renin secretion,76,0.17105263157894737,0.805
Apoptosis - multiple species,33,0.5454545454545454,0.812
Ferroptosis,42,0.2857142857142857,0.812
"Citrate cycle, second carbon oxidation, 2-oxoglutarate => oxaloacetate",14,0.42857142857142855,0.815
"Tyrosine degradation, tyrosine => homogentisate",8,0.375,0.825
Pancreatic secretion,116,0.1810344827586207,0.847
mTOR signaling pathway,158,0.4936708860759494,0.85
Bile secretion,100,0.22,0.853
Salivary secretion,88,0.375,0.855
Gastric acid secretion,75,0.28,0.864
Calcium signaling pathway,254,0.3937007874015748,0.865
Glycosphingolipid biosynthesis - globo and isoglobo series,17,0.17647058823529413,0.881
Efferocytosis,155,0.6451612903225806,0.885
Glycosphingolipid biosynthesis - lacto and neolacto series,28,0.21428571428571427,0.888
Steroid hormone biosynthesis,96,0.03125,0.888
Ether lipid metabolism,48,0.125,0.893
Serotonergic synapse,133,0.20300751879699247,0.893
"NADH dehydrogenase (ubiquinone) Fe-S protein/flavoprotein complex, mitochondria",11,0.2727272727272727,0.9
"Parathyroid hormone synthesis, secretion and action",108,0.5555555555555556,0.91
Biosynthesis of nucleotide sugars,38,0.18421052631578946,0.916
Cell cycle - G1/S transition,13,0.46153846153846156,0.92
TGF-beta signaling pathway,112,0.7410714285714286,0.921
RNA polymerase,36,0.08333333333333333,0.923
Cysteine and methionine metabolism,57,0.3508771929824561,0.928
Lysosome,136,0.25,0.935
Insulin secretion,86,0.47674418604651164,0.951
cGMP-PKG signaling pathway,175,0.5542857142857143,0.96
"Phosphatidylethanolamine (PE) biosynthesis, ethanolamine => PE",7,0.42857142857142855,0.978
Synaptic vesicle cycle,77,0.22077922077922077,0.978
Mismatch repair,22,0.7272727272727273,0.981
Morphine addiction,91,0.25274725274725274,0.982
Sulfur relay system,8,0.375,0.988
